Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis<sup>*</sup>

Zhao-ying LIANG; Cai-wen QIAN; Tao-hua LAN; Qiao-huang ZENG; Wei-hui LU; Wei JIANG

doi:10.1007/s11655-021-2877-9

Your Location：

Home >

Browse articles >

Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis^*

Review | Updated：2021-11-05

- Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis^*
- Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis^*
- Chinese Journal of Integrative Medicine 2021年27卷第11期页码：867-873
- Affiliations：
  
  1.State Key Laboratory of Dampness Syndrome of Chinese Medicine, Department of Cardiology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou (510020), China
  2.Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou (510020), China
  3.The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou (510405), China
  4.The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou (510020), China
- Author bio：
  
  Dr. JIANG Wei, E-mail: drjiangwei@126.com
- Funds：
  
  Science and Technology Planning Project of Guangdong Province(2018B030322012);National Natural Science Foundation of China(81874432;82074369)
- DOI：10.1007/s11655-021-2877-9
  中图分类号：
- 纸质出版日期：2021-11-01，
  
  网络出版日期：2021-09-16，
  
  录用日期：2021-07-30
Scan for full text
Zhao-ying LIANG, Cai-wen QIAN, Tao-hua LAN, 等. Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis^*[J]. Chinese Journal of Integrative Medicine, 2021,27(11):867-873.

Zhao-ying LIANG, Cai-wen QIAN, Tao-hua LAN, et al. Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis^*[J]. Chinese Journal of Integrative Medicine, 2021,27(11):867-873.
Zhao-ying LIANG, Cai-wen QIAN, Tao-hua LAN, 等. Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis^*[J]. Chinese Journal of Integrative Medicine, 2021,27(11):867-873. DOI： 10.1007/s11655-021-2877-9.

Zhao-ying LIANG, Cai-wen QIAN, Tao-hua LAN, et al. Regulatory T Cells: A New Target of Chinese Medicine in Treatment of Atherosclerosis^*[J]. Chinese Journal of Integrative Medicine, 2021,27(11):867-873. DOI： 10.1007/s11655-021-2877-9.

摘要

炎症反应和免疫紊乱在动脉粥样硬化(atherosclerosis

AS)发生和进展中是必不可少的. 调节性T细胞 (regulatory T cells

Tregs) 在抑制炎症和免疫调节中的作用日渐受到重视

大量研究显示Tregs的数量减少和功能障碍参与了AS的病变过程. 中医药在调节炎症和免疫反应方面具有双向、多靶点、低毒性的特点

动物与临床研究均表明

中医药可通过调节Tregs发挥抗动脉粥样硬化作用. 因此

本文简要介绍了Tregs的研究现状、Tregs与AS发生发展的关系以及中医药通过调节Tregs防治动脉粥样硬化性心脑血管疾病的研究进展. 尽管相关研究仍处于开始阶段

但已有的证据显示中医药干预Tregs以调节免疫功能可能是治疗AS疾病具有前景的方法之一.

Abstract

Inflammation and immune disorders are integral to the occurrence and progression of atherosclerosis (AS). With the role of regulatory T cells (Tregs) in immune regulation attracting attention

it has been widely accepted that Treg decrease and dysfunction are involved in AS pathogenesis. Chinese medicine (CM) has the advantages of being dual-directional

multi-targeted

and having minimal side effects in immune regulation. The anti-atherosclerosis effects of CM via Treg modulation have been revealed in clinical and animal studies. Therefore

this article reviews existing research on Tregs

the relationship between Tregs and AS

and the progress of CM for treating and prevention of atherosclerotic cardio-cerebrovascular diseases by regulating Tregs. Although the underlying mechanisms remain to be elucidated

CM treatment targeting Treg cells might provide a promising and novel future approach for prevention and treatment of AS.

关键词

Keywords

Chinese medicineatherosclerosisregulatory T cellsimmunizationinflammation

references

Schaftenaar F, Frodermann V, Kuiper J, et al.Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol 2016;27:209-215.

Bocian K, Kiernozek E, Domagala-Kulawik J, et al.Expanding diversity and common goal of regulatory T and B cells. Ⅰ: origin, phenotype, mechanisms. Arch Immunol Ther Exp (Warsz) 2017;65:501-520.

Albany CJ, Trevelin SC, Giganti G, et al. Getting to the heart of the matter: the role of regulatory T-cells (Tregs) in cardiovascular disease (CVD) and atherosclerosis. Front Immunol 2019;10:2795.

Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell 2008;133:775-787.

Hartigan-O'Connor DJ, Poon C, Sinclair E, et al. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 2007;319(1-2):41-52.

Vrabelova Z, Hrotekova Z, Hladikova Z, et al. CD 127- and FoxP3+ expression on CD25+CD4+ T regulatory cells upon specific diabetogeneic stimulation in high-risk relatives of type 1 diabetes mellitus patients. Scand J Immunol 2008;67:404-410.

Hori S, Nomura T, Sakaguchi S. Pillars article: control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.

Foks AC, Frodermann V, ter Borg M, et al. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis 2011;218:53-60.

Tselios K, Sarantopoulos A, Gkougkourelas I, et al. T regulatory cells: a promising new target in atherosclerosis.Crit Rev Immunol 2014;34:389-397.

Arce-Sillas A, Alvarez-Luquin DD, Tamaya-Dominguez B, et al. Regulatory T cells: Molecular actions on effector cells in immune regulation. J Immunol Res 2016;2016:1720827.

Glass CK, Witztum JL. Atherosclerosis, the road ahead.Cell 2001;104:503-516.

Ait-Oufella H, Salomon B L, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006;12:178-180.

Wang Z, Mao S, Zhan Z, et al. Effect of hyperlipidemia on Foxp3 expression in apolipoprotein E-knockout mice. J Cardiovasc Med (Hagerstown) 2014;15:273-279.

Klingenberg R, Gerdes N, Badeau RM, et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest 2013;123:1323-1334.

George J, Schwartzenberg S, Medvedovsky D, et al.Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis 2012;222:519-523.

Mor A, Luboshits G, Planer D, et al. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006;27:2530-2537.

Liu ZD, Wang L, Lu FH, et al. Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques. Inflamm Res 2012;61:1155-1165.

Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008;127:89-97.

Dietel B, Cicha I, Voskens CJ, et al. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis 2013;230:92-99.

Jia L, Zhu L, Wang JZ, et al. Methylation of Foxp3 in regulatory T cells is related to the severity of coronary artery disease. Atherosclerosis 2013;228:346-352.

Klingenberg R, Brokopp CE, Grives A, et al. Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes. Eur Heart J 2015;36:1041-1048.

Meng X, Yang J, Dong M, et al. Regulatory T cells in cardiovascular diseases. Nat Rev Cardiol 2016;13:167-179.

Ou HX, Guo BB, Liu Q, et al. Regulatory T cells as a new therapeutic target for atherosclerosis. Acta Pharmacol Sin 2018;39:1249-1258.

Wang P, Zheng SG. Regulatory T cells and B cells:implication on autoimmune diseases. Int J Clin Exp Pathol 2013;6:2668-2674.

Lin J, Li M, Wang Z, et al. The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation. J Lipid Res 2010;51:1208-1217.

Foks AC, Frodermann V, ter Borg M, et al. Differential effects of regulatory T cells on the initiation and regression of atherosclerosis. Atherosclerosis 2011;218:53-60.

Mor A, Planer D, Luboshits G, et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:893-900.

Feng J, Zhang Z, Kong W, et al. Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice. Cardiovasc Res 2009;84:155-163.

Herbin O, Ait-Oufella H, Yu W, et al. Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012;32:605-612.

van Leuven SI, van Wijk DF, Volger OL, et al.Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis.Atherosclerosis 2010;211:231-236.

Liu C, Chapman NM, Karmaus PW, et al. mTOR and metabolic regulation of conventional and regulatory T cells.J Leukoc Biol 2015;97:837-847.

Worthington JJ, Kelly A, Smedley C, et al. Integrin alphavbeta8-mediated TGF-beta activation by effector regulatory T cells is essential for suppression of T-cell-mediated inflammation. Immunity 2015;42:903-915.

Kita T, Yamashita T, Sasaki N, et al. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovasc Res 2014;102:107-117.

Meng X, Zhang K, Li J, et al. Statins induce the accumulation of regulatory T cells in atherosclerotic plaque.Mol Med 2012;18:598-605.

Mausner-Fainberg K, Luboshits G, Mor A, et al. The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. Atherosclerosis 2008;197:829-839.

Hou X, Si Q, Jia Y, et al. Etiology and pathogenesis of atherosclerosis in traditional Chinese medicine. Hebei Univ Chin Med (Chin) 2018;33(6):9-11.

Zhou J, Deng J, Li N, et al. Effect of sinomenine combined with methotrexate on Treg and Th17 cells in peripheral blood of patients with RA and its clinical significance.Current Immun (Chin) 2013;33:46-51.

Li D, Yuan X, Yang L, et al. Effects of Jiedu Huayu Decoction on Th17/Treg cells and its cytokines on patients with active ulcerative colitis. J Emerg Tradit Chin Med (Chin)2018;27:16-19.

Yin H, Wang L, Gong W, et al. Clinical efficacy of Feiyanning Granule on Th17/Treg Imbalance in patients with advanced lung cancer. Guiding J Tradit Chin Med Pharm (Chin) 2017;23:34-38.

Li X, Cheng W, Huang L, et al. The impact of astragalosideⅣ on the experimentally atherosclerotic formation in ApoE-deficient mice. J Chin Physic (Chin) 2017;19:1817-1819.

Ding JW, Luo CY, Wang XA, et al. Glycyrrhizin, a high-mobility group Box 1 inhibitor, improves lipid metabolism and suppresses vascular inflammation in apolipoprotein E knockout mice. J Vasc Res 2018;55:365-377.

Gao S, Zhang W, Zhao Q, et al. Curcumin ameliorates atherosclerosis in apolipoprotein E deficient asthmatic mice by regulating the balance of Th2/Treg cells. Phytomedicine 2019;52:129-135.

Lv J, Xiong W, Lei T, et al. Amygdalin ameliorates the progression of atherosclerosis in LDL receptordeficient mice. Mol Med Rep 2017;16:8171-8179.

Zeng N, Xu M, Zhuang L. The effect of Danshensu on atherosclerosis in rats and its mechanisms. Immunol J(Chin) 2020;36:884-889.

Xu YY. Effect of oriental latrine fly larvina-effective fraction on mouse model of atherosclerosis and lymphocytes in vitro[dissertation]. Guangzhou: Guangdong Pharmaceutical University; 2013.

Liao P, Liu L, Wang B, et al. Baicalin and geniposide attenuate atherosclerosis involving lipids regulation and immunoregulation in ApoE-/- mice. Eur J Pharmacol 2014;740:488-495.

Fan Q, Liu Y, Rao J, et al. Anti-atherosclerosis effect of Angong Niuhuang Pill via regulating Th17/Treg immune balance and inhibiting chronic inflammatory on ApoE(-/-)mice model of early and mid-term atherosclerosis. Front Pharmacol 2019;10:1584.

Pang X, Wang Q, Chen S, et al. Effect and mechanism of Buyang Huanwu Tang on atherosclerotic plaque based on Treg cells. Chin J Exp Tradit Med Formulae (Chin) 2020;26(5):1-5.

Zhou F, Cheng S, Zhang Y, et al. Anti-atherosclerotic effect of a Chinese medicine, Huanglian Jiedu Decoction, mediated by regulatory T cells. Acta Laboratorium Animalis Scientia Sinica (Chin) 2016;24:233-238.

Chen XN, Ge QH, Zhao YX, et al. Effect of Si-Miao-Yong-An decoction on the differentiation of monocytes, macrophages, and regulatory T cells in ApoE(-/-) mice. J Ethnopharmacol 2021;276:114178.

Wan Q, Liu Z. Effect of Dingxin Recipe in inhibiting atherosclerosis induced by PM2.5 by p-regulating CD4+CD25+Foxp3+ regulatory T cells expression. Chin J Exp Tradit Med Formulae (Chin) 2018;24:139-144.

Qiu R, Zhou L, Ma Y, et al. Effects of Yangyin Recipe on imbalance of Th17 and Treg cells in ApoE-/- mice under HSP65 attack. Chin Tradit Herbal Drugs (Chin)2019;50:1122-1130.

Ma Y, Qiu R, Yuan D, et al. Effects of YHF on expression of Treg in apolipoprotein E knockout mice. Tradit Chin Drug Res Clin Pharmacol (Chin) 2018;29:313-318.

Qiu R, Long J, Zhou L, et al. Yangyin Qingre Huoxue method in traditional Chinese medicine ameliorates atherosclerosis in ApoE(-/-) mice suffering from high-fat diet and HSP65 aggression. Evid Based Complement Alternat Med 2019;2019:2531979.

L Zhou L, Ma Y, Sun Y, et al. Effects of Yangyin Huoxue Prescription on the imbalance of Treg/Th17 and atherosclerosis in ApoE-/- mice induced by high-fat diet. J China Pharm Univ (Chin) 2020;51:60-67.

Jiang T, Ji W, Sui Y, et al. Effects of New Xuefu Zhuyu Decoction on the expression of immunomodulatory factors HMGB- 1 and Foxp3 in atherosclerosis model rats. J Basic Chin Med (Chin) 2017;23:480-483.

Han M. Study the Zhilong Huoxue Tongyu Capsule improve early carotid atherosclerosis role based on TGF-β/Smads pathway [disserattion]. Luzhou: Southwest Medical University; 2020.

Liang WJ. Study on the efficacy and mechanism of Qima capsule in improving intimal thickening of carotid artery[disserattion]. Guangzhou: Guangzhou University of Chinese Medicine; 2018.

Zhou MC. The Clinical and experimental study on the effect of atherosclerosis by Tong Yang Kuang Xiong granules[disserattion]. Guangzhou: Guangzhou University of Chinese Medicine; 2018.

Peng L, Shen J, Wang Y, et al. Effects of Qishen Yiqi Dripping Pills on regulatory T cells in ApoE gene knockout mice with atherosclerosis. China J Tradit Chin Med Pharm(Chin) 2018;33:907-910.

Meng C, Zhuo XQ, Xu GH, et al. Protection of salvianolate against atherosclerosis via regulating the inflammation in rats.J Huazhong Univ Sci Technolog Med Sci 2014;34:646-651.

Hong Y, He Y, Yang Y, et al. Effect of Compound Danshen Dropping Pills combined with simvastatin treatment on level of regulatory T cells in patients with carotid atherosclerotic cerebral infarction. Chin Tradit Herbal Drugs (Chin)2017;48:1624-1628.

Ting Y, Fan G, Bo D. Interleukin-17 in patients with high-risk transient ischemic attack in posterior circulation. Herald Med (Chin) 2013;32:1583-1586.

Lu X. Effect of Tiangou Shixi Decoction in patients with acute cerebral infarction and its influence on neurological function, Tregs and VEGF levels in peripheral blood. J Sichuan Tradit Chin Med (Chin) 2020;38:117-120.

Belghith M, Bluestone JA, Barriot S, et al. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003;9:1202-1208.

Koutruba N, Emer J, Lebwohl M. Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis. Ther Clin Risk Manag 2010;6:123-141.

Yang Y, Liu Q, Zhou H, et al. The relationship between plaque microenvironment and yin-yang theory of traditional Chinese medicine. J Tradit Chin Med (Chin) 2020;61:862-865.

Zhang F, Zhai M, Wu Q, et al. Protective effect of Tong-Qiao-Huo-Xue Decoction on inflammatory injury caused by intestinal microbial disorders in stroke rats. Biol Pharm Bull 2020;43:788-800.

Pan R, Zhou M, Zhong Y, et al. The combination of Astragalus membranaceus extract and ligustrazine to improve the inflammation in rats with thrombolytic cerebral ischemia. Int J Immunopathol Pharmacol 2019;33:1681106303.

Yin Y, Li XL. Effects of yiqi huoxue decoction combined with nicodil on the therapeutic efficacy and T cell subsets in patients with stable angina pectoris. Shaanxi J Tradit Chin Med (Chin) 2020;41:888-890.

Wang Q, Lu W, Chen X. Effect of Yiqi Huoxue Huatan Tongluo formula on T-cell subset in patients with carotid atherosclerosis. Shaanxi J Tradit Chin Med (Chin)2019;40:307-310.

Jiao S. The clinical effect of Xuesaitong and its influence on immune function in patients with angina pectoris. Chin J Clin Rational Drug Use (Chin) 2020;13(30):82-84.

Yan J, Yu Y, Yan M, et al. Effects of Xuesaitong lyophilized powder injection combined with nicorandil on cardiac function and serum CD4+/CD8+ levels in patients with angina pectoris.Chin J Immunol (Chin) 2019;35:2532-2538.

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Inflammatory and Immunomodulatory Effects of Tripterygium wilfordii Multiglycoside in Mouse Models of Psoriasis Keratinocytes

Schisandrin B Protects against Ischemic Brain Damage by Regulating PI3K/AKT Signaling in Rats

Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κB-ROS/NLRP3 Pathway

Anti-inflammatory Effects of Ampelopsis Japonica Root on Contact Dermatitis in Mice

Schisandrin B Inhibits NLRP3 Inflammasome Pathway and Attenuates Early Brain Injury in Rats of Subarachnoid Hemorrhage